Modelling vortex interactions reveals distinct patterns of brain reconfiguration following psilocybin and escitalopram
Major depressive disorder is a leading cause of disability, yet how interventions reorganise brain dynamics remains poorly understood. Here, we investigated how psilocybin and escitalopram reshape brain dynamics in depression using pre- and post-treatment resting-state functional magnetic resonance imaging (fMRI) from a double-blind randomised controlled trial (NCT03429075). We compared two…
We haven't written up this one. bioRxiv has the full story — the link below goes straight to it.